Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Circulomics is a genomics sample-preparation and life science tools company best known for its Nanobind technology for extracting high-molecular-weight DNA for long-read sequencing workflows. The company originated as a Johns Hopkins spinout and evolved from earlier microRNA and single-molecule analysis work into commercialization of sequencing sample prep products. Its products have been used across human biomedical research, plant and animal science, microbiology, and other genomics applications. In August 2021, Circulomics was acquired by Pacific Biosciences, and its technologies became part of PacBio's broader end-to-end long-read sequencing workflow offering. The business is therefore best characterized as a commercial genomics tools/platform company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Circulomics.